XML 18 R7.htm IDEA: XBRL DOCUMENT v3.22.2.2
Consolidated Statements of Cash Flows - USD ($)
 12 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Operating Activities:    
Net loss $ (16,212,000) $ 704,000
Adjustments to reconcile net (loss) income to net cash (used in) provided by operating activities:    
Impairment of goodwill 13,162,000 0
Depreciation and amortization 2,556,000 1,597,000
Amortization of debt issuance costs 19,000 11,000
Provision for doubtful accounts 55,000 0
Warranty provision 86,000 54,000
Inventory obsolescence 333,000 379,000
Stock-based compensation 2,227,000 1,424,000
Realized loss on foreign currency forward contract 0 (76,000)
Deferred income taxes 666,000 433,000
Amortization of operating lease right of use asset 746,000 694,000
Accretion of acquisition holdback liability 48,000 46,000
Changes in operating assets and liabilities:    
Accounts receivable, net 836,000 (2,138,000)
Inventories, net 75,000 (846,000)
Prepaid expenses and other 242,000 253,000
Accounts payable 199,000 600,000
Accrued and other liabilities (4,570,000) 4,902,000
Net cash provided by operating activities 468,000 6,150,000
Investing Activities:    
Purchases of marketable securities (6,830,000) (5,144,000)
Proceeds from maturities of marketable securities 7,122,000 5,646,000
Cash paid for acquisitions net of cash acquired 0 (15,848,000)
Capital expenditures (381,000) (208,000)
Net cash used in investing activities (89,000) (15,554,000)
Financing Activities:    
Proceeds from exercise of stock options 282,000 210,000
Repurchase of common stock (998,000) 0
Shares retained for payment of taxes in connection with settlement of restricted stock units (70,000) (141,000)
Payments on promissory notes (277,000) (18,000)
Cash paid for debt issuance costs 0 (38,000)
Net cash (used in) provided by financing activities (1,063,000) 13,000
Effect of foreign exchange rate on cash (185,000) (77,000)
Net decrease in cash, cash equivalents, and restricted cash (869,000) (9,468,000)
Cash, cash equivalents and restricted cash, beginning of period 14,528,000 23,996,000
Cash, cash equivalents and restricted cash, end of period 13,659,000 14,528,000
Cash and cash equivalents 12,736,000 13,167,000
Restricted cash, current portion 100,000 279,000
Long-term restricted cash 823,000 1,082,000
Total cash, cash equivalents and restricted cash shown in the consolidated statement of cash flows 13,659,000 14,528,000
Noncash investing and financing activities:    
Change in unrealized loss on marketable securities (90,000) (7,000)
Common stock issued in connection with the purchase of Zonehaven 0 (10,938,000)
Obligation to issue common stock in connection with the Amika Mobile asset purchase (832,000) (1,248,000)
Initial measurement of operating lease right of use assets 466,000 259,000
Initial measurement of operating lease liabilities 466,000 259,000
Fair value of net assets acquired $ 0 $ 30,980,000